Noninvasive biomarkers in NAFLD and NASH - current progress and future promise.
Wong, Vincent Wai-Sun
Noninvasive biomarkers in NAFLD and NASH - current progress and future promise. [electronic resource] - Nature reviews. Gastroenterology & hepatology 08 2018 - 461-478 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1759-5053
10.1038/s41575-018-0014-9 doi
Biomarkers--metabolism
Biopsy--methods
Cytokines--metabolism
Diagnosis, Differential
Early Diagnosis
Elasticity Imaging Techniques--methods
Ferritins--metabolism
Forecasting
Genetic Markers--genetics
Hormones--metabolism
Humans
Insulin--metabolism
Keratin-18--metabolism
Lipid Metabolism--physiology
Liver Cirrhosis--pathology
Magnetic Resonance Imaging
Non-alcoholic Fatty Liver Disease--drug therapy
Oxidative Stress--physiology
Prognosis
Severity of Illness Index
Tissue Inhibitor of Metalloproteinase-1--metabolism
Tomography, X-Ray Computed
Ultrasonography
Weight Reduction Programs
Noninvasive biomarkers in NAFLD and NASH - current progress and future promise. [electronic resource] - Nature reviews. Gastroenterology & hepatology 08 2018 - 461-478 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1759-5053
10.1038/s41575-018-0014-9 doi
Biomarkers--metabolism
Biopsy--methods
Cytokines--metabolism
Diagnosis, Differential
Early Diagnosis
Elasticity Imaging Techniques--methods
Ferritins--metabolism
Forecasting
Genetic Markers--genetics
Hormones--metabolism
Humans
Insulin--metabolism
Keratin-18--metabolism
Lipid Metabolism--physiology
Liver Cirrhosis--pathology
Magnetic Resonance Imaging
Non-alcoholic Fatty Liver Disease--drug therapy
Oxidative Stress--physiology
Prognosis
Severity of Illness Index
Tissue Inhibitor of Metalloproteinase-1--metabolism
Tomography, X-Ray Computed
Ultrasonography
Weight Reduction Programs